Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 126:
127. The compound of claim 125, wherein the compound is of formula (II-A-1):, , or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof,
wherein:
R2 is phenyl, 1,2,3,4-tetrahydronaphthalen-5-yl, 1,2,3,4-tetrahydronaphthalen-6-yl, 1,2,3,4-tetrahydronaphthalen-7-yl, or 1,2,3,4-tetrahydronaphthalen-8-yl; and
wherein the phenyl, 1,2,3,4-tetrahydronaphthalen-5-yl, 1,2,3,4-tetrahydronaphthalen-6-yl, 1,2,3,4-tetrahydronaphthalen-7-yl, or 1,2,3,4-tetrahydronaphthalen-8-yl is optionally substituted by 1, 2, 3, or 4 independently selected R2d substituents.